Skip to main content
. 2023 Mar 23;13:1–8. doi: 10.1016/j.sopen.2023.03.007
Postoperative variables Overall (N = 1191) ERP non-failure (N = 918) ERP failure (N = 273) p value
HLOS, median (Q1, Q3) 4 (3.0–6.0) 3 (2.0–4.0) 10 (8.0–16.0) <0.01
Readmission, n (%) 152 (12.8) 108 (11.8) 44 (16.1) 0.06
Any complication, n (%) 252 (21.2) 121 (13.2) 131 (47.9) <0.01
Renal failure, n (%) 4 (0.3) 1 (0.1) 3 (1.1) 0.01
Clostridium difficile infection, n (%) 8 (0.7) 4 (0.4) 4 (1.5) 0.07
Deep SSI, n (%) 12 (1.0) 7 (0.8) 5 (1.8) 0.12
Myocardial infarction, n (%) 4 (0.3) 2 (0.2) 2 (0.7) 0.2
Postop ventilator requirement, n (%) 7 (0.6) 3 (0.3) 4 (1.5) 0.03
Organ space infection, n (%) 78 (6.6) 35 (3.8) 43 (15.8) <0.01
Postop pneumonia, n (%) 8 (0.7) 0 (0) 8 (2.9) <0.01
Postop acute kidney injury (AKI), n (%) 11 (0.9) 4 (0.4) 7 (2.6) <0.01
Pulmonary thromboembolism (PTE), n (%) 2 (0.2) 2 (0.2) 0 (0) 0.44
Postop sepsis, n (%) 21 (1.8) 11 (1.2) 10 (3.7) <0.01
Superficial SSI, n (%) 41 (3.4) 23 (2.5) 18 (6.6) <0.01
Postop transfusion, n (%) 85 (7.1) 37 (4.0) 48 (17.6) <0.01
Intubation, n (%) 9 (0.8) 2 (0.2) 7 (2.6) <0.01
Urinary tract infection (UTI), n (%) 15 (1.3) 11 (1.2) 4 (1.5) 0.73
Deep venous thrombosis (DVT), n (%) 9 (0.8) 2 (0.2) 7 (2.6) <0.01

Bold font represents significant p values <0.05.